To investigate the bioavailability and potential of HO2 as a therapeutic biomarker of metastatic cancer, we measured HO2 expression levels across various cancer cell lines, including A549, HepG2, AGS, HCT116, MDA-MB-435s, and MCF-7 cells. Here, HMOX2 is linked to metastatic malignant neoplasm.